Mankind Pharma, a pharmaceutical company, has received a 14% subscription for its initial public offering (IPO) on the first day of sale. The National Stock Exchange (NSE) has reported bids for 40.57 lakh shares against 2.80 crore shares offered. Retail Individual Investors (RIIs) subscribed to 10% of the category and non-institutional investors subscribed to 33%. The Qualified Institutional Buyers (QIBs)…
